Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT01745900Unknown

Evaluation and Comparison of Noninvasive Blood Glucose Concentrations

Role: collaborator

NCT01415544Unknown

Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References

Role: lead

NCT01168115Completed

Near-Infrared Spectroscopy for Blood Glucose Measurements

Role: lead

NCT01168102Completed

Noninvasive Blood Ethanol Measurement With Infrared Spectroscopy

Role: lead

NCT01168089Completed

Near Infrared Spectroscopy for Blood Glucose Measurement in Critical Care Settings

Role: lead

NCT01168076Completed

Noninvasive Transcutaneous Glucometer Development

Role: lead

NCT00358254Completed

Noninvasive Skin Spectroscopy for Diabetes Screening

Role: lead

All 7 trials loaded